Pancreatic cancer and thromboembolic disease. (Q35937439)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15522652%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

review article

1 reference

title

Pancreatic cancer and thromboembolic disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15522652%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15522652%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Robert L Fine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15522652%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

language of work or name

1 reference

1 November 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15522652%20AND%20SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15522652%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15522652%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15522652%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

655-663

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15522652%20AND%20SRC:MED&resulttype=core&format=json

Malignancy, thrombosis and Trousseau: the case for an eponym.

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Biomedicine. Clotting factors build blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Factor VIIIa-induced gene expression: potential implications in pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Tissue factor expression correlates with histological grade in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Pancreatic cancer complicated by disseminated intravascular coagulation associated with production of tissue factor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Mechanism of thrombin-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Characterization of functional thrombin receptors in human pancreatic tumor cells (MIA PACA-2)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Expression of the thrombin receptor PAR-1 correlates with tumour cell differentiation of pancreatic adenocarcinoma in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Thrombin enhances adhesion in pancreatic cancer in vitro through the activation of the thrombin receptor PAR 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Potentiation of endothelial cell proliferation by fibrin(ogen)-bound fibroblast growth factor-2

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Tumor cell-induced platelet aggregation in vitro by human pancreatic cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Cancer and the prothrombotic state

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Markers of Coagulation and Angiogenesis in Cancer-Associated Venous Thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Cancer and thromboembolic disease: pathogenic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Prognosis of Cancers Associated with Venous Thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Two patients with arterial thromboembolism among 311 patients with adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

1 reference

7 January 2021

Spontaneous arterial thrombosis in association with pancreatic carcinoma: diagnosis and interventional management

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Neoadjuvant preoperative chemoradiation in patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Trousseau's syndrome and acute arterial thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Portal venous stent placement in patients with pancreatic and biliary neoplasms invading portal veins and causing portal hypertension: initial experience

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Thromboembolism in hospitalized neutropenic cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Prevention of venous thromboembolism in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Prevention of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Observations on the developmental patterns and the consequences of pancreatic exocrine adenocarcinoma. Findings of 154 autopsies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Management of venous thromboembolism: past, present, and future

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

The Günther Tulip retrievable filter: prolonged temporary filtration by repositioning within the inferior vena cava

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Hemostatic regulators of tumor angiogenesis: a source of antiangiogenic agents for cancer treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Relationship between cyclooxygenase-2 inhibition and thrombogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

Will oral antithrombin agents replace warfarin?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901606-7

7 January 2021

10.1016/S1470-2045(04)01606-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15522652%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15522652%20AND%20SRC:MED&resulttype=core&format=json